Business Development Services
Life Sciences Advisory at Wells Therapeutics Inc. is a strategic service that bridges pharmaceutical innovation between China and the United States. This advisory is built on decades of cross-border clinical development experience from global leaders such as Pfizer, Takeda, Novartis, GSK, Roche, Bayer, and AbbVie
Sourcing Chinese Innovation for U.S/Global market
The service is delivered through three integrated platforms designed to support both Western and Chinese companies
Proprietary Deal Flow
Finding early-stage, pre-databased assets through extensive local networks.
Scientific Due Diligence
Providing comprehensive clinical data assessment and scientific review.
Intelligence
Offering "behind-the-scenes" insights into partner capabilities and potential "red flags".
Deal Support
Assisting with deal structuring, negotiation, and ongoing alliance management
Global Partnering Advisory for Chinese Biotechs
This platform assists Chinese companies looking for international partnerships.
Clinical Strategy:
Developing FDA-aligned global clinical strategies and optimizing trials for competitive differentiation.
Material Preparation:
Optimizing data packages and creating investor-grade materials.
Network Engagement:
Facilitating Key Opinion Leader (KOL) engagement and scientific advisory support.
Relationship Management:
Identifying partners and facilitating deal-making and cross-cultural communication.
China Clinical Trial Execution Support
For Western companies conducting trials in China, this platform provides on-ground operational support to ensure global standards are met
Expert Selection of CROs:
Wells meticulously identifies and partners with mid-sized Contract Research Organizations (CROs) in China.
On-the-Ground Management:
The company provides essential on-site support and project management.
Regulatory Navigation:
Clients receive comprehensive guidance through China's unique and evolving regulatory and CMC (Chemistry, Manufacturing, and Controls) frameworks
Trial Type Determination:
Wells uses its expertise to advise whether a study should be classified as an Investigator-Initiated Trial (IIT) or a Registrational Trial.
Interested in learning more about our comprehensive services?